Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.67421 | 28 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.67636 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.67955 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.64087 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.62071 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.69696 | 27 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.67271 | 28 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.25095 | 52 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.66358 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.66586 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66261 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.65972 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.6498 | 28 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.66648 | 30 |